102
Views
23
CrossRef citations to date
0
Altmetric
Articles

HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILD HEMATOLOGIC MALIGNANCIES WITH G-CSF-MOBILIZED MARROW GRAFTS WITHOUT T-CELL DEPLETION: A Single-Center Report of 45 Cases

, MD, , MD, , MD, , MD, , MD, , MD, , MD, , MD & , MD show all
Pages 119-128 | Received 15 Jul 2008, Accepted 21 Sep 2008, Published online: 09 Jul 2009

REFERENCES

  • Spitzer T R. Haploidentical stem cell transplantation: The always present but overlooked donor. Hematology Am Soc Hematol Educ Program 2005; 390–395
  • Guinan E C, Boussiotis V A, Neuberg D, et al. Transplantation of anergic histoincompatible bone marrow allografts. N Engl J Med 1999; 340: 1704–1714
  • Ji S, Chen H, Wang H, et al. Low incidence of severe aGVHD and accelerating hemopoietic reconstitution in allo-BMT using lenograstim stimulated BM cells. Chin Med J. 2001; 114: 191–195
  • Isola L M, Scigliano E, Skerrett D, et al. A pilot study of allogeneic bone marrow transplantation using related donors stimulated with G-CSF. Bone Marrow Transplant 1997; 20: 1033–1037
  • Serody J S, Sparks S D, Lin Y, et al. Comparison of granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood progenitor cells and G-CSF-stimulated bone marrow as a source of stem cells in HLA-matched sibling transplantation. Biol Blood Marrow Transplant 2000; 6: 434–440
  • Morton J, Hutchins C, Durrant S. Granulocyte-colony-stimulating factor (G-CSF) primed allogeneic bone marrow: Significantly less graft-vs-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells. Blood 2001; 98: 3186–191
  • Marks D I, Khattry N, Cummins M, et al. Haploidentical stem cell transplantation for children with acute leukemia. Br J Haematol 2006; 134: 196–201
  • Goldman F D, Rumelhart S L, DeAlacron P, et al. Poor outcome in children with refractory/relapsed leukemia undergoing bone marrow transplantation with mismatched family member donors. Bone Marrow Transplant 2000; 25: 943–948
  • Petersdorf E W, Mickelson E M, Anasetti C, et al. Effect of HLA mis-matched on the outcome of hematopoietic transplants. Curr Opin Immunol 1999; 11: 521–526
  • Al-Kasim F A, Thornley I, Rolland M, et al. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: Similar survival after matched-related and -unrelated donor transplants. Br J Haematol 2002; 116: 483–490
  • Svennilson J, Remberger M, Ringden O. Risk factors for moderate-to-severe acute graft-vs-host disease after allogeneic stem cell transplantation in children. Pediatr Transplant 2003; 7: 130–136
  • Beatty P G, Clift R A, Mickelson E M, et al. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 1985; 313: 765–771
  • Aversa F, Tabilio A, Velardi A, et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 1998; 339: 1186–1193
  • Yoshihara T, Morimoto A, Nakauchi S, et al. Successful transplantation of haploidentical CD34+ selected bone marrow cells for an infantile case of severe combined immunodeficiency with aspergillus pneumonia. Pediatr Hematol Oncol 2002; 19: 439–443
  • Ringhoffer M, Wiesneth M, Harsdorf S, et al. CD34+ cell selection of peripheral blood progenitor cells using the CliniMACS device for allogeneic tansplantation:clinical results in 102 patients. Br J Heamatol 2004; 126: 527–535
  • Henslee-Downey P J, Abhyankar S H, Parrish R S, et al. Use of partially mismatched related donoes extends access to allogeneic marrow transplant. Blood 1997; 89: 3864–3872
  • Ji S Q, Chen H R, Wang H X, et al. G-CSF primed haploidenticalmarrow transplantation without ex-vivo T cell depletion: An ex-cellent alternative for high-risk leukemia. Bone Marrow Transpl 2002; 30: 861–866
  • Nachbaur D, Eibl B, Kropshofer G, et al. In vivo T cell depletion with low-dose rabbit antithymocyte globulin results in low transplant-related mortality and low relapse incidence following unrelated hematopoietic stem cell transplantation. J Hematother Stem Cell Res 2002; 11: 731–737
  • Harris D T, Sakiestewa D, Lyons C, et al. Prevention of graft-versus-host disease (GVHD) by elimination of recipient-reactive donor T cells with recombinant toxins that target the interleukin2 (IL-2) receptor. Bone Marrow Transpl 1999; 23: 137–144
  • Aversa F, Velardi A, Tabilio A, et al. Haploidentical stem cell transplantation in leukemia. Blood Rev 2001; 15: 111–119
  • Meyer S, Reinhard H, Gottschling S, et al. Pulmonary dysfunction in pediatric oncology patients. Pediatr Hematol Oncol 2004; 21: 175–195
  • Kook H, Goldman F, Padley D, et al. Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: Immunophenotypic analysis and factors affecting the speed of recovery. Blood 1996; 88: 1089–1097

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.